Department of Family Medicine, Seoul National University Hospital, Seoul, South Korea.
Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea.
Public Health. 2021 Jan;190:23-29. doi: 10.1016/j.puhe.2020.10.023. Epub 2020 Dec 15.
We aimed to determine whether there are any differences in all-cause and cause-specific mortality with cardiovascular disease (CVD) risk between health screening attenders and non-attenders among young adults.
We performed a retrospective cohort study using claim data from the Korean National Health Insurance Service database.
Individuals aged 20-39 years who had received health screening at least once between 2002 and 2005 were classified as attenders, and the others were classified as non-attenders. After propensity score matching according to attendance of health screening, 2,060,409 attenders and 2,060,409 non-attenders were included. We estimated adjusted hazard ratios (HRs) and 95% confidence interval (CI) for all-cause mortality, cause-specific mortality, and hospitalization of CVD from 2006 to 2015.
Survival from all-cause mortality was greater among attenders than among non-attenders (log rank P < 0.001). Similarly, death from CVD (log rank P = 0.007) and CVD events (log rank P < 0.001) were less likely among attenders. The risk for all-cause mortality in attenders was significantly lower than that in non-attenders (HR = 0.83, 95% CI = 0.81 to 0.84). The risk for CVD mortality (HR = 0.80, 95% CI = 0.73 to 0.87) and hospitalization of CVD (HR = 0.92, 95% CI = 0.91 to 0.94) were lower in attenders. In stratified analyses, the risk for all-cause and cause-specific mortalities was lower among attenders regardless of insurance type.
Among young adults, the risk for all-cause mortality, CVD mortality, and hospitalization of CVD were lower for those who underwent health screenings. Future studies that evaluate the cost-effectiveness of health screening with additional consideration of psychosocial aspects are needed.
本研究旨在确定在年轻人中,进行健康筛查者与未进行健康筛查者的心血管疾病(CVD)风险与全因死亡率和死因死亡率之间是否存在差异。
本研究采用了来自韩国国家健康保险服务数据库的索赔数据进行回顾性队列研究。
将 2002 年至 2005 年间至少接受过一次健康筛查的 20-39 岁个体归类为筛查参与者,其他个体归类为非筛查参与者。根据健康筛查的参与情况进行倾向评分匹配后,纳入了 2060409 名筛查参与者和 2060409 名非筛查参与者。我们估计了 2006 年至 2015 年全因死亡率、死因死亡率和 CVD 住院率的校正风险比(HR)和 95%置信区间(CI)。
与非筛查参与者相比,筛查参与者的全因死亡率更高(对数秩 P<0.001)。同样,CVD 死亡(对数秩 P=0.007)和 CVD 事件(对数秩 P<0.001)在筛查参与者中发生的可能性较低。筛查参与者的全因死亡率风险明显低于非筛查参与者(HR=0.83,95%CI=0.81 至 0.84)。CVD 死亡率(HR=0.80,95%CI=0.73 至 0.87)和 CVD 住院率(HR=0.92,95%CI=0.91 至 0.94)的风险在筛查参与者中较低。在分层分析中,无论保险类型如何,筛查参与者的全因和死因死亡率风险均较低。
在年轻人中,进行健康筛查者的全因死亡率、CVD 死亡率和 CVD 住院率风险较低。未来需要进行更多考虑心理社会因素的健康筛查成本效益评估的研究。